XELJANZ 11 mg prolonged-release tablets
Licence Info section shown.
| Licence number | Strength | ATC Code | Dosage Form |
|---|---|---|---|
| EU/1/17/1178/010 | 11 mg | L04AA29 | Prolonged-release tablet |
| EU/1/17/1178/011 | 11 mg | L04AA29 | Prolonged-release tablet |
| EU/1/17/1178/012 | 11 mg | L04AA29 | Prolonged-release tablet |
| EU/1/17/1178/013 | 11 mg | L04AA29 | Prolonged-release tablet |
- Licence number
- EU/1/17/1178/010
- Strength
- 11 mg
- ATC Code
- L04AA29
- Dosage Form
- Prolonged-release tablet
- Licence number
- EU/1/17/1178/011
- Strength
- 11 mg
- ATC Code
- L04AA29
- Dosage Form
- Prolonged-release tablet
- Licence number
- EU/1/17/1178/012
- Strength
- 11 mg
- ATC Code
- L04AA29
- Dosage Form
- Prolonged-release tablet
- Licence number
- EU/1/17/1178/013
- Strength
- 11 mg
- ATC Code
- L04AA29
- Dosage Form
- Prolonged-release tablet
Pfizer Healthcare Ireland Unlimited Company
The Watermarque Building, Ringsend Road, Dublin 4, D04 K7N3, Ireland, D04 K7N3 Dublin
- Telephone
- +3531800633363